相关实验视频

Updated: Jun 10, 2025

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

基于 thiazepine 的混合物作为有前途的抗结肠癌药物:设计,合成,计算和体外查

Mahesh D Vaghasiya¹, Arindam Sain², Jigarkumar V Mendapara¹

¹Department of Chemistry, S.V. National Institute of Technology, Surat, Gujarat, 395007, India.

Chemistry & biodiversity

|October 16, 2024

概括

新型 thiazepine 杂交物显示出强大的抗结肠癌活性. 化合物9b,9c和9d对HT-29细胞具有显著的细胞毒性,为新的结肠癌疗法铺平了道路.

科学领域:

药用化学医学化学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

结肠癌仍然是一个重大的全球健康挑战.
开发具有高疗效和安全性的新型治疗剂至关重要.

研究的目的:

设计和合成基于 thiazepine 的新型混合物,作为抗结肠癌治疗的潜在分子.
评估这些化合物对结肠癌细胞的体外细胞毒性作用.
以计算方式评估药理动力学和安全性概况 (ADMET).

主要方法:

合成基于 thiazepine 的杂交物 (化合物 9a-d).
使用IR,NMR和HR-MS分析技术进行表征.
在体外细胞毒性测定HT-29结肠癌细胞在24小时和48小时.
在中预测ADMET用于药理动力学和安全性分析.

主要成果:

所有合成的化合物都表现出对HT-29细胞的剂量依赖性细胞毒性.
化合物9b,9c和9d显示出显著的疗效,9d在48小时暴露时特别强效 (50%的细胞死亡在~5μM).
与其他测试混合物相比,化合物9a的细胞毒性较低.
在 silico 研究提供了对潜在药物标和安全性概况的见解.

结论:

基于 thiazepine 的混合物代表了结肠癌治疗的有希望的候选人.
化合物9b,9c和9d需要进一步调查,因为它们是主要的抗结肠癌药物.
这项研究强调了这些新型化合物的潜力,以探索对结肠癌的机械作用.

关键词:

结肠直肠癌是一种癌症.计算分析计算分析欧洲农业基金会 (EGFR) 是一个基金.的HT-29细胞.这是一种 thiazepine 杂交物.

更多相关视频

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

相关概念视频

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: 5-HT₃ Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...